Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal D Shore

Showing results (151-160 of 312) with videos related to

Pageof 32
Sort By:
Future Oncology (London, England)|August 16, 2023
Plain language summary: Can declines in prostate-specific antigen level indicate how long patients with advanced prostate cancer will live when treated with enzalutamide?Maha Hussain, Cora N Sternberg, Eleni Efstathiou, et al.
Clinical Genitourinary Cancer|April 16, 2023
Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate CancerDaniel J George, Fred Saad, Michael S Cookson, et al.
The Lancet. Oncology|April 13, 2026
Pain and health-related quality-of-life outcomes with darolutamide in metastatic hormone-sensitive prostate cancer (ARANOTE): secondary and exploratory analyses of a multicentre, randomised, placebo-controlled, phase 3 trialAlicia K Morgans, Kunhi Parambath Haresh, Mindaugas Jievaltas, et al.
Clinical Genitourinary Cancer|December 3, 2014
Combining immunotherapy and radiation for prostate cancerSteven E Finkelstein, Sharon Salenius, Constantine A Mantz, et al.
Urology|July 17, 2012
Role of testosterone in managing advanced prostate cancerKyle O Rove, Frans M Debruyne, Bob Djavan, et al.
Prostate Cancer and Prostatic Diseases|April 20, 2024
Correction: A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancerNeal D Shore, Emmanuel S Antonarakis, Ashley E Ross, et al.
Reviews in Urology|January 28, 2017
Prostate Cancer Academy 2016: Presentation summariesE David Crawford, David M Albala, James S Wysocki, et al.
The Oncologist|October 9, 2023
Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS TrialNeal D Shore, Maha Hussain, Fred Saad, et al.
Urology|November 28, 2017
Absorbable Hydrogel Spacer Use in Prostate Radiotherapy: A Comprehensive Review of Phase 3 Clinical Trial Published DataLawrence I Karsh, Eric T Gross, Christopher M Pieczonka, et al.
Urology|March 26, 2014
Long-term tolerability and efficacy of degarelix: 5-year results from a phase III extension trial with a 1-arm crossover from leuprolide to degarelixE David Crawford, Neal D Shore, Judd W Moul, et al.
Pageof 32

Showing results (151-160 of 312) with videos related to

Sort By:
Pageof 32
Future Oncology (London, England)|August 16, 2023
Plain language summary: Can declines in prostate-specific antigen level indicate how long patients with advanced prostate cancer will live when treated with enzalutamide?Maha Hussain, Cora N Sternberg, Eleni Efstathiou, et al.
Clinical Genitourinary Cancer|April 16, 2023
Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate CancerDaniel J George, Fred Saad, Michael S Cookson, et al.
The Lancet. Oncology|April 13, 2026
Pain and health-related quality-of-life outcomes with darolutamide in metastatic hormone-sensitive prostate cancer (ARANOTE): secondary and exploratory analyses of a multicentre, randomised, placebo-controlled, phase 3 trialAlicia K Morgans, Kunhi Parambath Haresh, Mindaugas Jievaltas, et al.
Clinical Genitourinary Cancer|December 3, 2014
Combining immunotherapy and radiation for prostate cancerSteven E Finkelstein, Sharon Salenius, Constantine A Mantz, et al.
Urology|July 17, 2012
Role of testosterone in managing advanced prostate cancerKyle O Rove, Frans M Debruyne, Bob Djavan, et al.
Prostate Cancer and Prostatic Diseases|April 20, 2024
Correction: A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancerNeal D Shore, Emmanuel S Antonarakis, Ashley E Ross, et al.
Reviews in Urology|January 28, 2017
Prostate Cancer Academy 2016: Presentation summariesE David Crawford, David M Albala, James S Wysocki, et al.
The Oncologist|October 9, 2023
Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS TrialNeal D Shore, Maha Hussain, Fred Saad, et al.
Urology|November 28, 2017
Absorbable Hydrogel Spacer Use in Prostate Radiotherapy: A Comprehensive Review of Phase 3 Clinical Trial Published DataLawrence I Karsh, Eric T Gross, Christopher M Pieczonka, et al.
Urology|March 26, 2014
Long-term tolerability and efficacy of degarelix: 5-year results from a phase III extension trial with a 1-arm crossover from leuprolide to degarelixE David Crawford, Neal D Shore, Judd W Moul, et al.
Pageof 32